Please login to the form below

Not currently logged in
Email:
Password:

Alapis acquires Pharmalex for USD 19.5m

Greek chemical and pharmaceutical company Alapis has acquired 99.7 per cent of pharmaceutical company Pharmalex for EUR 14.3m (USD 19.5m).

Greek chemical and pharmaceutical company Alapis has acquired 99.7 per cent of pharmaceutical company Pharmalex for EUR 14.3m (USD 19.5m).

Greece-headquartered Pharmalex is not operational at the moment but previously ran production and distribution activities in the region.

The company owns production facilities of 7,500 square metres in Pallini in the Attica basin, on a land plot totalling 13,900 square metres.

According to Alapis management, the company will modernise and expand these production facilities to create a research and development laboratory, and will eventually absorb Pharmalex.

The Pharmalex purchase is the latest in a raft of buy ups across central and southern Europe. Alapis has established two companies, one in Serbia and another in Hungary, both of which will specialise in the production and trade of veterinary medicines and foods.

The Serbia-based operation is called Veterin Pharma Doo and has its headquarters in Beograd. The other company, based in Budapest, Hungary, is called Veterin Hungary. Alapis is the sole share holder in both companies.

Alapis already co-operates with Germany-headquartered Bayer on the production of veterinary drugs in Greece, Romania and Bulgaria.

13th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics